Inventor · disambiguated record
Marie Layzell
Also filed as: LAYZELL MARIE · LAYZELL MARIE CLAIRE
9 granted patents·9 pending applications·55 citations·filing 2017–2025
85Inventor score
Top patents by PatentIndex Score
18 records- 0195US11660289B2Deuterated or partially deuterated N,N-dimethyltryptamine compoundsSMALL PHARMA LTD·Filed 2022·Granted May 30, 2023·11 cites·15 claims
- 0295US11471417B2Deuterated N,N-dimethyltryptamine compoundsSMALL PHARMA LTD·Filed 2021·Granted Oct 18, 2022·16 cites·12 claims
- 0394US11697638B25-methoxy-N,N-dimethyltryptamine crystalline formsSMALL PHARMA LTD·Filed 2021·Granted Jul 11, 2023·10 cites·19 claims
- 0493US11406619B2Injectable formulationsSMALL PHARMA LTD·Filed 2021·Granted Aug 9, 2022·18 cites·20 claims
- 0575US12251371B2Deuterated or partially deuterated N,N-dimethyltryptamine compoundsCYBIN UK LTD·Filed 2023·Granted Mar 18, 2025·0 cites·19 claims
- 0673US12343327B2Injectable formulationsCYBIN UK LTD·Filed 2022·Granted Jul 1, 2025·0 cites·19 claims
- 0769US12042564B2Therapeutic solid dosage formsCYBIN UK LTD·Filed 2021·Granted Jul 23, 2024·0 cites·21 claims
- 0869US2025262187A1Injectable formulationsCYBIN UK LTD·Filed 2025·Application pending·0 cites
- 0965US2024342101A1Therapeutic solid dosage formsCYBIN UK LTD·Filed 2024·Application pending·0 cites
- 1062US2022306569A1Crystalline forms of hydroxynorketamineSMALL PHARMA LTD·Filed 2022·Application pending·0 cites
- 1158US12318477B2Injectable and inhalable formulationsCYBIN UK LTD·Filed 2022·Granted Jun 3, 2025·0 cites·21 claims
- 1258US11377416B2Crystalline forms of hydroxynorketamineSMALL PHARMA LTD·Filed 2018·Granted Jul 5, 2022·0 cites·4 claims
- 1357US2025032450A1Injectable and inhalable formulationsCYBIN UK LTD·Filed 2022·Application pending·0 cites
- 1449US2022168274A1Parenteral FormulationSMALL PHARMA LTD·Filed 2020·Application pending·0 cites
- 1548US2022062237A1Injectable formulationSMALL PHARMA LTD·Filed 2020·Application pending·0 cites
- 1648US2025262145A1Injectable and inhalable formulationsCYBIN UK LTD·Filed 2025·Application pending·0 cites
- 1743US2021315840A1Solid oral dosage forms of ketamine derivativesSMALL PHARMA LTD·Filed 2018·Application pending·0 cites
- 1840US2019380978A1Solid oral dosage forms of 2r,6r-hydroxynorketamine or derivatives thereofSMALL PHARMA LTD·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Marie Layzell files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →